PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 93 filers reported holding PLIANT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $727,320 | -5.2% | 41,918 | -1.0% | 0.00% | – |
| Q2 2023 | $767,129 | +68.6% | 42,336 | +147.5% | 0.00% | – |
| Q1 2023 | $455,045 | +142.0% | 17,107 | +75.9% | 0.00% | – |
| Q4 2022 | $188,003 | +358.5% | 9,726 | +67.9% | 0.00% | – |
| Q1 2022 | $41,000 | -47.4% | 5,792 | 0.0% | 0.00% | – |
| Q4 2021 | $78,000 | -19.6% | 5,792 | +0.6% | 0.00% | – |
| Q3 2021 | $97,000 | +1.0% | 5,756 | +74.3% | 0.00% | – |
| Q2 2021 | $96,000 | -26.7% | 3,302 | -0.5% | 0.00% | – |
| Q1 2021 | $131,000 | +403.8% | 3,319 | +190.6% | 0.00% | – |
| Q4 2020 | $26,000 | 0.0% | 1,142 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -83.9% | 1,142 | -77.2% | 0.00% | – |
| Q2 2020 | $161,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |